Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000674201 | SCV000799499 | pathogenic | Fanconi anemia complementation group A | 2018-04-23 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostics Laboratory, |
RCV000674201 | SCV000889965 | pathogenic | Fanconi anemia complementation group A | 2018-07-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001069523 | SCV001234696 | pathogenic | Fanconi anemia | 2023-10-06 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg591*) in the FANCA gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FANCA are known to be pathogenic (PMID: 19367192). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Fanconi anemia (PMID: 9371798, 10521298, 21273304, 22778927, 29098742). ClinVar contains an entry for this variant (Variation ID: 557990). For these reasons, this variant has been classified as Pathogenic. |
Ce |
RCV003222094 | SCV003917867 | pathogenic | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | FANCA: PVS1, PM2, PM3:Supporting |
Baylor Genetics | RCV000674201 | SCV004196112 | pathogenic | Fanconi anemia complementation group A | 2023-05-22 | criteria provided, single submitter | clinical testing | |
Leiden Open Variation Database | RCV000674201 | SCV001425670 | pathogenic | Fanconi anemia complementation group A | 2020-02-28 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitters to LOVD: Arleen D. Auerbach, Johan de Winter, Sue Richards. |